These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 15520163)
1. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163 [TBL] [Abstract][Full Text] [Related]
2. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703 [TBL] [Abstract][Full Text] [Related]
3. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells. Lin HK; Hu YC; Lee DK; Chang C Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473 [TBL] [Abstract][Full Text] [Related]
4. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088 [TBL] [Abstract][Full Text] [Related]
5. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Bandyopadhyay S; Wang Y; Zhan R; Pai SK; Watabe M; Iiizumi M; Furuta E; Mohinta S; Liu W; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Hai T; Watabe K Cancer Res; 2006 Dec; 66(24):11983-90. PubMed ID: 17178897 [TBL] [Abstract][Full Text] [Related]
6. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover. Maehama T; Okahara F; Kanaho Y Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605 [TBL] [Abstract][Full Text] [Related]
7. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Bandyopadhyay S; Pai SK; Gross SC; Hirota S; Hosobe S; Miura K; Saito K; Commes T; Hayashi S; Watabe M; Watabe K Cancer Res; 2003 Apr; 63(8):1731-6. PubMed ID: 12702552 [TBL] [Abstract][Full Text] [Related]
8. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650 [TBL] [Abstract][Full Text] [Related]
9. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. McMenamin ME; Soung P; Perera S; Kaplan I; Loda M; Sellers WR Cancer Res; 1999 Sep; 59(17):4291-6. PubMed ID: 10485474 [TBL] [Abstract][Full Text] [Related]
10. PTEN and myotubularin: novel phosphoinositide phosphatases. Maehama T; Taylor GS; Dixon JE Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408 [TBL] [Abstract][Full Text] [Related]
12. The role of PTEN in the progression and survival of prostate cancer. Deocampo ND; Huang H; Tindall DJ Minerva Endocrinol; 2003 Jun; 28(2):145-53. PubMed ID: 12717346 [TBL] [Abstract][Full Text] [Related]
13. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304 [TBL] [Abstract][Full Text] [Related]
14. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. Grünwald V; DeGraffenried L; Russel D; Friedrichs WE; Ray RB; Hidalgo M Cancer Res; 2002 Nov; 62(21):6141-5. PubMed ID: 12414639 [TBL] [Abstract][Full Text] [Related]
15. FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis. Bandyopadhyay S; Pai SK; Watabe M; Gross SC; Hirota S; Hosobe S; Tsukada T; Miura K; Saito K; Markwell SJ; Wang Y; Huggenvik J; Pauza ME; Iiizumi M; Watabe K Oncogene; 2005 Aug; 24(34):5389-95. PubMed ID: 15897909 [TBL] [Abstract][Full Text] [Related]
16. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062 [TBL] [Abstract][Full Text] [Related]
17. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569 [TBL] [Abstract][Full Text] [Related]
18. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Unoki M; Nakamura Y Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141 [TBL] [Abstract][Full Text] [Related]
19. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Takano Y; Saito K; Piquemal D; Commes T; Watabe M; Gross SC; Wang Y; Ran S; Watabe K Oncogene; 2004 Jul; 23(33):5675-81. PubMed ID: 15184886 [TBL] [Abstract][Full Text] [Related]
20. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]